IOL Chemicals and Pharmaceuticals Ltd
NSE:IOLCP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Adcock Ingram Holdings Ltd
OTC:AIHLF
|
ZA |
|
InterDigital Inc
NASDAQ:IDCC
|
US |
|
R
|
RFG Holdings Ltd
JSE:RFG
|
ZA |
|
CE Info Systems Ltd
NSE:MAPMYINDIA
|
IN |
|
A
|
Aeris Industria e Comercio de Equipamentos para Geracao de Energia SA
BOVESPA:AERI3
|
BR |
|
Amrutanjan Health Care Ltd
NSE:AMRUTANJAN
|
IN |
|
Riverside Resources Inc
XTSX:RRI
|
CA |
|
A
|
Avid Technology Inc
F:AVD
|
US |
|
Metalurgica Gerdau SA
BOVESPA:GOAU4
|
BR |
|
SVG Tech Group Co Ltd
SZSE:300331
|
CN |
|
Southstone Minerals Ltd
XTSX:SML
|
CA |
|
Hellofresh SE
XETRA:HFG
|
DE |
|
KIYO Learning Co Ltd
TSE:7353
|
JP |
|
Renewi PLC
LSE:RWI
|
UK |
|
Duckyang Industry Co Ltd
KRX:024900
|
KR |
|
Tameny Inc
TSE:6181
|
JP |
|
Melia Hotels International SA
MAD:MEL
|
ES |
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| IN |
|
IOL Chemicals and Pharmaceuticals Ltd
NSE:IOLCP
|
21.4B INR |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
869B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
588.6B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
227.8B GBP |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
297.7B USD |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
231.9B CHF |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
159.7B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.1B USD |
Loading...
|
Market Distribution
| Min | -153 833.3% |
| 30th Percentile | 2.7% |
| Median | 7.3% |
| 70th Percentile | 13.2% |
| Max | 9 977% |
Other Profitability Ratios
IOL Chemicals and Pharmaceuticals Ltd
Glance View
IOL Chemicals & Pharmaceuticals Ltd. engages in the manufacture of organic and inorganic chemical compounds. The company is headquartered in Ludhiana, Punjab and currently employs 2,316 full-time employees. The company went IPO on 2010-11-05. The firm is engaged in manufacturing and selling of organic chemicals, specialty, intermediates, and bulk drugs. Its product portfolio covers various therapeutic categories, such as Pain Management, Anti-diabetic, Anti-hypertensive, and Anti-convulsant, amongst others. Its active pharma ingredients (API) product portfolio include Ibuprofen, Ibuprofen Lysinate, Ibuprofen Sodium, Dex-Ibuprofen, Metformin HCL, Clopidogrel Bisulphate (Form II), Pantoprazole Sodium, Fenofibrate, Gabapentin, Lamotrigine, Ursodeoxycholic Acid, Losartan Potassium and Levetiracetam. Its specialty chemical division include Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride and Mono Chloro Acetic Acid. The firm caters to the pharmaceutical and specialty chemical requirements across both domestic and international markets. The company serves Austria, Belgium, Hungry, Spain, Germany, Italy, Netherlands, Switzerland and others.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for IOL Chemicals and Pharmaceuticals Ltd is 7.2%, which is below its 3-year median of 7.5%.
Over the last 3 years, IOL Chemicals and Pharmaceuticals Ltd’s Operating Margin has increased from 5.9% to 7.2%. During this period, it reached a low of 5.8% on Sep 30, 2024 and a high of 9.9% on Sep 30, 2023.
